EMA/HMA joint statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

News

EU news

EMA/HMA joint statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU

Online download statistics by month:

Online download statistics by month: October 2022 to August 2024

	Abstract	Full	Pdf
Oct 2022	250	3	1
Nov 2022	613	12	6
Dec 2022	336	3	3
Jan 2023	98	3	3
Feb 2023	119	1	1
Mar 2023	132	4	2
Apr 2023	153	0	0
May 2023	147	0	3
Jun 2023	93	0	0
Jul 2023	107	2	1
Aug 2023	63	15	14
Sep 2023	125	2	2
Oct 2023	53	3	1
Nov 2023	74	2	1
Dec 2023	68	0	1
Jan 2024	35	3	1
Feb 2024	33	2	2
Mar 2024	43	2	0
Apr 2024	61	0	0
May 2024	60	1	1
Jun 2024	57	3	1
Jul 2024	156	3	2
Aug 2024	29	2	1
Total	2905	66	47